GlassScriptPhysician profile
Stephanie Pham
NPI 1003588922
$6,301.45
in general payments reported to CMS, 2019-2025
30 companies · $1,214 in 2025
The $1,214 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,299 · 2023: $1,476 · 2024: $2,313 · 2025: $1,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,002.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $854.18 | 2022-2025 | Krystexxa, Otezla, Repatha |
| Abbvie INC. | $825.56 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $634.94 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $620.16 | 2022-2025 | |
| Glaxosmithkline, LLC. | $533.09 | 2022-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Novo Nordisk INC | $522.62 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Phathom Pharmaceuticals, INC. | $428.74 | 2024-2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $390.51 | 2022-2025 | Jardiance |
| Lilly USA, LLC | $353.55 | 2022-2025 | Jardiance, Mounjaro, Emgality |
| Pfizer INC. | $128.52 | 2023-2025 | |
| Exact Sciences Corporation | $110.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Kowa Pharmaceuticals America, INC. | $109.44 | 2022-2024 | Seglentis, Livalo, Zoryve |
| Ironwood Pharmaceuticals, INC | $100.86 | 2022-2024 | Linzess |
| Mannkind Corporation | $84.31 | 2022 | |
| Gilead Sciences, INC. | $80.58 | 2023-2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $64.40 | 2025 | Andembry, Hizentra, Haegarda |
| Aimmune Therapeutics, INC. | $62.29 | 2024-2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.11 | 2022-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $56.83 | 2022-2025 | Vaxneuvance, Gardasil 9, Capvaxive |
| Nestle Healthcare Nutrition INC. | $52.14 | 2022 | |
| Novartis Pharmaceuticals Corporation | $43.75 | 2023-2025 | |
| Sanofi Pasteur INC. | $39.31 | 2022-2023 | |
| Sobi, INC | $26.48 | 2023 | |
| Astellas Pharma US INC | $22.45 | 2023 | Veozah |
| Dexcom, INC. | $21.97 | 2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $20.81 | 2022 | |
| Inspire Medical Systems, INC. | $17.17 | 2025 | Inspire |
| Vbi Vaccine (Delaware) INC. | $13.20 | 2022 | |
| Redhill Biopharma INC. | $12.38 | 2022 | |
| Cranial Technologies, INC | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.